Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID-19 (Severe Coronavirus Disease 2019)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT04838847
What this trial is testing

Evaluate the Immunogenicity and Safety of the SARS-CoV-2 mRNA Vaccine CVnCoV in Elderly Adults Compared to Younger Adults for COVID-19

Who this might be right for
CoronavirusCovid19SARS-CoV-2+1 more
CureVac
Testing effectiveness (Phase 2)UnknownNCT04338802
What this trial is testing

Efficacy and Safety of Nintedanib in the Treatment of Pulmonary Fibrosis in Patients With Moderate to Severe COVID -19

Who this might be right for
COVID-19NintedanibSafety+1 more
Huilan Zhang 96
Large-scale testing (Phase 3)UnknownNCT04780672
What this trial is testing

Clinical Study in the Treatment of Patients With COVID-19

Who this might be right for
COVID-19
Pharma VAM 330
Testing effectiveness (Phase 2)Study completedNCT04561219
What this trial is testing

Nitazoxanide Therapy for Patients With COVID-19 Pneumonia

Who this might be right for
Covid19Corona Virus InfectionPneumonia, Viral
Universidade Federal do Rio de Janeiro 500
Not applicableStudy completedNCT04602351
What this trial is testing

Communication in ICU During COVID-19

Who this might be right for
COVID-19Severe Acute Respiratory Syndrome Coronavirus 2Severe Acute Respiratory Syndrome
NMC Specialty Hospital 296
Very early researchWithdrawnNCT04323631
What this trial is testing

Hydroxychloroquine for the Treatment of Patients With Mild to Moderate COVID-19 to Prevent Progression to Severe Infection or Death

Who this might be right for
COVID-19
Rambam Health Care Campus
Not applicableStudy completedNCT07244731
What this trial is testing

The Prognostic Role of Red Blood Cell Distribution (RDW) in Severe COVID-19 Patients

Who this might be right for
COVID - 19PrognosisICU
Ankara University 146
Large-scale testing (Phase 3)Study completedNCT04960202
What this trial is testing

EPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19

Who this might be right for
COVID-19
Pfizer 2,091
Post-approval studies (Phase 4)Active Not RecruitingNCT07086222
What this trial is testing

Efficacy and Safety of NVX-CoV2705

Who this might be right for
COVID-19Sars-CoV-2 Infection
Novavax 6,500
Not applicableStudy completedNCT04368845
What this trial is testing

Telerehabilitation in Patients With COVID-19 After Hospitalization. The ATHLOS Study

Who this might be right for
COVID-19Comorbidities and Coexisting Conditions
University of Thessaly 82
Not applicableUnknownNCT04357847
What this trial is testing

Assessment of Endothelial and Haemostatic Changes During Severe SARS-CoV-2 Infection

Who this might be right for
Covid-19Endothelial DysfunctionThrombosis+1 more
University Hospital, Rouen 100
Not applicableUnknownNCT05946538
What this trial is testing

Clinical Evaluation of SARS-COV-2 (COVID-19), Influenza and RSV 8-Well MT-PCR Panel for In Vitro Diagnostics

Who this might be right for
Respiratory Viral Infection
AusDiagnostics Pty Ltd. 1,000
Testing effectiveness (Phase 2)Study completedNCT04401423
What this trial is testing

TXA127 for the Treatment of Severe COVID-19

Who this might be right for
COVID-19
Columbia University 22
Testing effectiveness (Phase 2)WithdrawnNCT05085574
What this trial is testing

Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1)

Who this might be right for
2019 Novel Coronavirus Disease2019 Novel Coronavirus Infection2019-nCoV Disease+9 more
Leidos Life Sciences
Not applicableUnknownNCT05160779
What this trial is testing

Impact of Genetic Polymorphisms of Vasoactive Peptides on the Prognosis of Patients With COVID19

Who this might be right for
Sars-CoV-2 Infection
Leonardo Paroche de Matos 151
Early research (Phase 1)Study completedNCT04839146
What this trial is testing

Safety and Tolerability of COVID-19 Vaccine (ABNCoV2)

Who this might be right for
Covid19Severe Acute Respiratory SyndromeSARS-CoV-2 Infection
Radboud University Medical Center 45
Not applicableUnknownNCT05364060
What this trial is testing

COVID-19 and Mental Health in Eure

Who this might be right for
COVID-19 PandemicPsychiatric Disorder
Centre Hospitalier Eure-Seine 585
Not applicableStudy completedNCT06360770
What this trial is testing

Assessement of Microcirculation With NIRS Predicts Sepsis Development in Patients With Severe Covid-19 Pneumonia

Who this might be right for
Sepsis
General and Teaching Hospital Celje 35
Not applicableUnknownNCT05890560
What this trial is testing

Two-year Efficacy of Three Exercise Rehabilitation Strategies on Dyspnea in Patients Who Presented With Secondary Respiratory Distress Syndrome Secondary to Severe COVID-19 Pneumonia

Who this might be right for
DyspneaCOVID-19
Fondation Hôpital Saint-Joseph 120
Testing effectiveness (Phase 2)Ended earlyNCT04404361
What this trial is testing

PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer

Who this might be right for
COVID19COVID-19COVID
CTI BioPharma 200
Next Page